Eli Lilly Inks Multibillion-Dollar Pact to Develop Precision Cancer Therapies
Tickers: $LLY
Topics: biotechnology drug development oncology strategic partnership
Read the full article at Benzinga
Part of the story Eli Lilly Strengthens Market Position with Retatrutide Clinical Success (3 articles)